Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells:: Role of caspase-8 and mitochondria

被引:21
作者
Ameyar-Zazoua, M
Larochette, N
Dorothée, G
Daugas, E
Haddada, H
Gouloumet, V
Métivier, D
Stancou, R
Mami-Chouaib, F
Kroemer, G
Chouaib, S
机构
[1] Inst Gustave Roussy, INSERM U487, Lab Cytokines & Immunol Tumeurs Humaines, F-94805 Villejuif, France
[2] Inst Gustave Roussy, CNRS UMR1599, F-94805 Villejuif, France
[3] Inst Gustave Roussy, INSERM U362, F-94805 Villejuif, France
关键词
p53; TNF; mitochondria; caspase-8;
D O I
10.1038/sj.cgt.7700434
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In the present study, we have investigated the mechanisms by which the restoration of wild-type (wt) p53 functions in p53 mutant cells increases their susceptibility to the cytotoxic action of tumor necrosis factor (TNF). Our data indicate that the resistance of p53-mutated cl.1001 cells to TNF-induced cell death was not due to a defect in the expression of TRADD and FADD, yet correlated with a reduced caspase-8 activation as well as a deficient mitochondrial membrane permeabilization. Moreover, cl.1001 cells failed to translocate the mitochondrial AIF and cytochrome c to the nucleus and to the cytosol, respectively, in response to TNF. Sensitization of these cells, following infection with a recombinant adenovirus encoding wtp53, to TNF-induced cytotoxicity resulted in the restoration of caspase-8 cleavage and the reestablishment of mitochondrial signs of apoptosis. These findings suggest that the crosstalk between p53 and TNF-induced cell death depends on mitochondria and that the combination of TNF and Adwtp53 may be a potential strategy to sensitize mutant p53 TNF-resistant tumors to the cytotoxic action of this cytokine.
引用
收藏
页码:219 / 227
页数:9
相关论文
共 50 条
[41]   Radiosensitivity of human breast cancer cells transduced with wild-type p53 gene is influenced by the p53 status of parental cells [J].
Maeda, T ;
Matsubara, H ;
Koide, Y ;
Sugaya, M ;
Miyazawa, Y ;
Tasaki, K ;
Isono, K ;
Ochiai, T ;
Sakiyama, S ;
Tagawa, M .
ANTICANCER RESEARCH, 2000, 20 (2A) :869-874
[42]   Wild-type p53 protects normal cells against apoptosis induced by thiostrepton [J].
Halasi, Marianna ;
Schraufnagel, Dean P. ;
Gartel, Andrei L. .
CELL CYCLE, 2009, 8 (17) :2850-2851
[43]   GENOMIC STABILITY AND WILD-TYPE P53 FUNCTION OF LYMPHOBLASTOID-CELLS WITH GERM-LINE P53 MUTATION [J].
LALLE, P ;
MOYRETLALLE, C ;
WANG, Q ;
VIALLE, JM ;
NAVARRO, C ;
BRESSACDEPAILLERETS, B ;
MAGAUD, JP ;
OZTURK, M .
ONCOGENE, 1995, 10 (12) :2447-2454
[44]   The Stapled Peptide PM2 Stabilizes p53 Levels and Radiosensitizes Wild-Type p53 Cancer Cells [J].
Mortensen, Anja Charlotte Lundgren ;
Spiegelberg, Diana ;
Brown, Christopher John ;
Lane, David Philip ;
Nestor, Marika .
FRONTIERS IN ONCOLOGY, 2019, 9
[45]   Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene [J].
Lang, FF ;
Yung, WKA ;
Raju, U ;
Libunao, F ;
Terry, NHA ;
Tofilon, PJ .
JOURNAL OF NEUROSURGERY, 1998, 89 (01) :125-132
[46]   An overview of the functions of p53 and drugs acting either on wild- or mutant-type p53 [J].
Huang, Yongmi ;
Jiao, Zhihao ;
Fu, Yuqing ;
Hou, Yue ;
Sun, Jinxiao ;
Hu, Feiran ;
Yu, Shangzhe ;
Gong, Kexin ;
Liu, Yiru ;
Zhao, Guisen .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 265
[47]   The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 association [J].
Yoichi Nagata ;
Tadashi Anan ;
Tetsuo Yoshida ;
Tamio Mizukami ;
Yoichi Taya ;
Toshiyoshi Fujiwara ;
Hirohisa Kato ;
Hideyuki Saya ;
Mitsuyoshi Nakao .
Oncogene, 1999, 18 :6037-6049
[48]   The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 association [J].
Nagata, Y ;
Anan, T ;
Yoshida, T ;
Mizukami, T ;
Taya, Y ;
Fujiwara, T ;
Kato, H ;
Saya, H ;
Nakao, M .
ONCOGENE, 1999, 18 (44) :6037-6049
[49]   Comparison of cellular characteristics between human hepatoma cell lines with wild-type p53 and those with mutant-type p53 gene [J].
Pu, H ;
Tsuji, T ;
Kondo, A ;
Fushimi, K ;
Ohashi, R ;
Inoue, Y ;
Mimura, T ;
Hamazaki, K ;
Miyazaki, M ;
Namba, M .
ACTA MEDICA OKAYAMA, 1997, 51 (06) :313-319
[50]   Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes [J].
Amy Willis ;
Eun Joo Jung ;
Therese Wakefield ;
Xinbin Chen .
Oncogene, 2004, 23 :2330-2338